Anti-spike – Page 28 – Communicable Diseases Research

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

Research Article

Published on 2020-10-072022-10-29
Journal: Science Translational Medicine
[Category] COVID-19, MERS, SARS,

[키워드] acute respiratory syndrome adaptive immune responses Adults age Anti-spike Antibody titer Antibody-dependent cellular phagocytosis antiviral immune response caused CD25 CD4 Cellular immune response children circulating clinical manifestation clinical outcomes Concentration concentrations coronavirus coronavirus disease correlated COVID-19 cytokine described difference disease evidenced Factor Frequency generate hospital Hospitalization Hospitalized human coronaviruses humoral identify IFN-γ IL-17A IL-6 immune response increased expression Inflammatory interferon-γ interleukin-17A lower mortality mechanical ventilation mechanisms modulate Mortality mounted Necrosis Neutralizing antibody titer New York City no difference outcome Patient patients with COVID-19 pediatric Pediatric patient people with COVID-19 Pierce Protein response robust SARS-CoV-2 SARS-COV-2 infection serum Serum neutralizing antibody syndrome T cell T cell response T cells TNF-α viral spike protein with COVID-19 younger patients
[DOI] 10.1126/scitranslmed.abd5487 PMC 바로가기 [Article Type] Research Article

Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings

여러 COVID-19 혈청 기술에 대한 비교 평가는 병원 및 지역사회 의료 환경에서 현장 진료 측면 흐름 분석의 지속적인 평가를 지원합니다.

Research Article

Published on 2020-09-242022-08-13
Journal: PLoS Pathogens
[Category] COVID-19, Medicine and Health Sciences, SARS,

[키워드] analysis Anti-spike antibody antibody levels Antibody test antibody test kits Antibody testing antibody tests approved Asymptomatic best binding domain Blood chemiluminescence chemiluminescence-based platform colloidal gold Community Comparative complement conducted COVID-19 delayed-onset syndrome delayed-onset syndromes dependent on determine Diagnosis diagnostic diagnostic antibody diagnostic antibody test diagnostic capabilities diagnostic capability disease ELISA evaluated gold head Head-to-head comparison healthcare hospital house in-house ELISA in-house ELISAs individual Inflammatory lateral flow lateral flow immunoassay Lateral flow immunoassays London management Mild multiple sero-diagnostic assay multiple sero-diagnostic assays nose swab Novel coronavirus nucleocapsid onset of symptoms paediatric inflammatory multisystem syndrome past Patient Patient management PCR-based throat and nose swab tests PIMS platform point-of-care point-of-care technology rapid lateral flow immunoassays RBD Receptor binding domain sampling SARS-CoV-2 SARS-CoV-2 antibody test SARS-CoV-2 infections sensitivities sensitivity serological Seven shown specificity Support Symptoms syndrome the epidemic utility Variation variety virus with COVID-19
[DOI] 10.1371/journal.ppat.1008817 PMC 바로가기 [Article Type] Research Article

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

Article

Published on 2020-09-172022-10-04
Journal: Nature Communications
[Category] SARS, 진단,